12/23/2025
A Phase 2 clinical trial testing the oral therapy GLPG3667 in people with systemic lupus erythematosus has failed to meet its main goal. https://buff.ly/5c48aVg
We are dedicated to sharing the latest news, research, and lupus patient perspectives.
Pensacola, FL
| Monday | 8am - 5pm |
| Tuesday | 8am - 5pm |
| Wednesday | 8am - 5pm |
| Thursday | 8am - 5pm |
| Friday | 8am - 5pm |
| Saturday | 8am - 2pm |
| Sunday | 9am - 5pm |
Be the first to know and let us send you an email when Lupus News Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.